+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 9Years - 15Years
All Genders
ID04532190

Testing Repetitive Transcranial Magnetic Stimulation as a New Treatment for Children and Teens with ADHD Aged 9 to 15 Years

Led by University of Calgary · Updated on 2026-05-14

30

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Attention-DeficitHyperactivity Disorder ADHD is marked by difficulties with attention, impulsivity, hyperactivity, and emotional regulation, affecting about 5% of children. Researchers are exploring whether a non-invasive brain stimulation called repetitive transcranial magnetic stimulation rTMS can reduce ADHD symptoms as an alternative to standard stimulant medications, which often have side effects and may not work for everyone. The study involves applying active rTMS to the right prefrontal cortex of children aged 9 to 15 years. Participants will receive rTMS treatments five times a week for four weeks. The design includes baseline and post-intervention assessments with MRI scans, neuropsychological tests, and various scales to measure attention and other symptoms. During the trial, children will undergo evaluations before and after the rTMS treatment period, including brain imaging and tests to assess attention and quality of life. Researchers will measure changes using the TEACh-2 tool at baseline and week 5, along with other scales over the course of the study. The total participation includes the treatment and follow-up assessments to monitor effects and safety.

CONDITIONS

Brief Title

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here